BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | $75.00 | Underperform → Neutral | BofA Securities |
| 4/14/2025 | $81.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 2/13/2025 | $85.00 → $89.00 | Underweight → Equal Weight | Barclays |
| 1/17/2025 | $91.00 | Peer Perform → Outperform | Wolfe Research |
| 10/7/2024 | $88.00 → $84.00 | Equal Weight → Underweight | Barclays |
| 5/28/2024 | $85.00 → $95.00 | Neutral → Buy | Citigroup |
| 5/24/2024 | $80.00 → $103.00 | Equal Weight → Overweight | Wells Fargo |
| 5/23/2024 | $96.00 | Market Perform → Outperform | BMO Capital Markets |
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
SD - DuPont de Nemours, Inc. (0001666700) (Filer)
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
Company marks significant progress towards 2050 climate goals WILMINGTON, Del., May 27, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs). This milestone underscores the company's commitment to achieving its renewable energy goal and acting on climate stewardship as part of its 2030 Sustainability Goals, as well as marking a key step towards DuPont's commitment of net-zero carbon emissions by 2050. "At DuPon
Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago periodGAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 millionGAAP EPS from continuing operations of $(1.33); adjusted EPS of $1.03Cash provided by operating activities from continuing operations of $382 million; transaction-adjusted free cash flow of $212 millionMaintaining full year 2025 financial guidance; separately providing tariff impact sensitivityWILMINGTON, Del., May 2, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the first quarter ende
WILMINGTON, Del., April 29, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on June 16, 2025, to holders of record of said stock at the close of business on May 30, 2025. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers a
Company marks significant progress towards 2050 climate goals WILMINGTON, Del., May 27, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs). This milestone underscores the company's commitment to achieving its renewable energy goal and acting on climate stewardship as part of its 2030 Sustainability Goals, as well as marking a key step towards DuPont's commitment of net-zero carbon emissions by 2050. "At DuPon
Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications WILMINGTON, Del., May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioprocessing portfolio with the launch of DuPont™ AmberChrom™ TQ1 chromatography resin for the purification of oligonucleotides and peptides in support of a wide-range of biopharma applications. "The introduction of DuPont™ AmberChrom™ TQ1 chromatography resin supports the accelerated development and commercialization of oligonucleotide and peptide therapeutics," said Shane Kendra, Global B
CAMBRIDGE, Mass. and WILMINGTON, Del., May 20, 2025 /PRNewswire/ -- Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, and DuPont Personal Protection (DuPont) (NYSE:DD), a global leader in personal protection solutions, have agreed to work together to explore opportunities to potentially enhance worker safety and well-being. Drawing on DuPont's expertise in protective garments and Epicore's wearable hydration management technology, this collaboration can help to drive new data analytics and quantitative insights at the intersection of advanced biometrics and personal protective clothing.
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)
WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c
Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's
Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui
BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00
KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00
Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)